This guideline covers managing hyperphosphataemia in children, young people and adults with stage 4 or 5 chronic kidney disease. Active ingredients Size Unit NHS indicative price Drug tariff Drug tariff price; Disodium hydrogen phosphate anhydrous 5.75 gram per 1 litre; Potassium dihydrogen phosphate 1.295 gram per 1 litre Sodium glycerophosphate 21.6% injection (Glycophos ®) will be available as an alternative. Guidelines for the management of hypomagnesaemia in Adult Clinical Haematology Authorised by: Dr Andy Peniket/Nadjoua Maouche ... Oxford University Hospitals NHS Trust. If in doubt contact a senior colleague or expert. This, together with a rising prevalence of CKD, led to the development of this clinical guideline on the management of hyperphosphataemia. Management of Hypophosphataemia Introduction. Learn more about Hypophosphataemia; see Hypophosphataemia page. Shortage of Supply - Phosphate Polyfusor 500ml - May 2020. Alternative products and administration advice: Phosphate Polyfusor ® contains 50mmol phosphate and 81mmol sodium in 500ml. Administration: Peripheral Administration By IV infusion at a rate of 0.05mmol/kg/hour (0.5mL/kg/hour of The interpretation and application of clinical guidelines remains the responsibility of the individual clinician. Phosphate Polyfusor® contains 50mmol phosphate, 81mmol sodium and 9.5mmol potassium in a 500mL bag. Please see our Prescribing Guidelines page for all prescribing guidance relating to this chapter. It is immune mediated. 20ml vial contains Phosphate 40 mmol (2 mmol/ml) Sodium 30 mmol (1.5 mmol/ml), Potassium 30 mmol (1.5 mmol/ml). Department of Clinical Haematology H.95 Page 5 of 5 November 2015 V.1.0. Phosphate tests are very useful for measuring phosphate levels in malnourished people (where their diet doesn't contain the right amount of nutrients to meet their body's demands). REFEEDING SYNDROME GUIDELINE FOR ADULTS Management of a patient at risk of refeeding: All Patients Monitor U&E, Mg, Ca and PO prior to feeding and daily until stable. Hypophosphataemia may be asymptomatic, but clinical symptoms usually become apparent when plasma phosphate concentrations fall below 0.3mmol/L. imum rate of 9mmol of phosphate over 12hrs (faster rates may be given in ITU), therefore 90ml of Phosphate Polyfusor in 12hrs, administer at 7.5ml/hour (total of 180mls). PHOSPHATE SANDOZ Effervescent Tablets contain sodium acid phosphate, anhydrous, sodium bicarbonate and potassium bicarbonate (all of which are subject to pharmacopoeial monographs). Sodium glycerophosphate 21.6% injection (Glycophos®) will be available as an alternative Alternative products and administration advice Phosphate Polyfusor® contains 50mmol phosphate and 81mmol sodium in 500ml. Possible symptoms include: weakness, anorexia, malaise, tremor, paraesthesia, seizures, acute respiratory failure, arrhythmias, altered mental status and hypotension. Non Formulary Items: Phosphate Polyfusor ® Non Formulary Sodium phosphate neutral : Non Formulary: Unlicensed formulation: oral solution 1mmol in 1ml 10mls/kg/day of Phosphate polyfusor® provides 1mmol/kg phosphate, 1.6mmol/kg sodium and 0.2mmol/kg potassium. Products available: Phosphate polyfusor contains 50mmol phosphate in 500mL (0.1mmol phosphate/mL). procedures and relevant guidelines. Definition of hypophosphataemia : Serum Phosphate <0.8mmol/L Nutrition/Blood related Shared Care Agreements. Phosphate may be incompatible with metal ions such as magnesium and calcium. See the guideline for renal transplantation in children. See Trust Electrolyte Guidelines Burosumab (Crysvita) Formulary Phosphate Polyfusor ® Formulary There is a national shortage of phosphate polyfusor. The physiological, pharmacological and clinical toxicity of potassium salts are well documented and limited animal data are therefore available. Methods: Patients with refeeding syndrome and normal renal function received a Phosphates Polyfusor infusion for the treatment of severe hypophosphataemia (< 0.50 mmol/L). May 2015. Sodium bicarbonate 8.4% 10mL ampoules (1mmol of sodium and 1mmol of bicarbonate per mL). This preparation should be infused alone, via a dedicated port of a central line, and if given peripherally should have a dedicated cannula. Phosphate <0.4mmol/l – replace with iv Polyfusor phosphate 500mls / 12 hours via CVC or PVC. Phosphate Polyfusor®: 9mmol (90ml) of phosphate over 12hrs. Phosphate Sandoz ® contains sodium dihydrogen phosphate anhydrous (anhydrous sodium acid phosphate) 1.936 g, sodium bicarbonate 350 mg, potassium bicarbonate 315 mg, equivalent to phosphorus 500 mg (phosphate 16.1 mmol), sodium 468.8 mg (Na + 20.4 mmol), potassium 123 mg (K + 3.1 mmol); Polyfusor NA ® contains Na + 162 mmol/litre, K + 19 mmol/litre, PO 4 3-100 mmol/litre; … Phosphate Polyfusor 500ml – Supply Disruption Phosphate Polyfusor® will be out of stock until at least October 2020. Back to top. Links. Products available: Sodium bicarbonate 1.26% 500mL polyfusor (0.15mmol of sodium and 0.15mmol of bicarbonate per mL). As an alternative BSUH will be using unlicensed Sodium Glycerophosphate injection 21.6% (1 x 10mL vial contains 10mmol phosphate and 20mmol sodium). Paediatric Nephrology and Urology Unit Authors: Meeta Mallik, Andrew Wignell Updated: April 2015 Peter Foxon Review: April 2018 Sodium Bicarbonate Presentation: Injection 4.2% (0.5 mmol/mL); 10mL vial and 500mL Polyfusor. The aetiology is unknown but the history often identifies a preceeding throat/URTI infection … Commence correction of electrolyte deficits prior to feeding if possible, peripheral replacement may be suitable (see overleaf). Phosphate 0.4-0.6 mmol/l – if symptomatic treat as above (consider oral). Guideline for the treatment of acute hypophosphataemia in adults, March 2016. 14 SCREENS You may be asked to send blood for different screening tests. Repeat serum phosphate, U&E, Mg2+, Ca2+ and Albumin after end of infusion. See oncology guidelines Resuscitation See Trust resuscitation guidelines. Note the polyfusor also contains 81mmol sodium and 9.5mmol potassium in 500mL. ... Nottingham University Hospitals NHS Trust. 1 INTRODUCTION ... Phosphate ≤ 0.80 Phosphate Sandoz 2 TDS (16mmol/each) 7.5ml/hr over 12 hours (9mmol) of phosphate polyfusor . Follow the Trust hypophosphataemia guideline for ADULTS. 500ml; 1000ml PAT Guideline… Give over 20 hours unless on PICU when can be given over a minimum of 2 hours. Exercise care in renal failure. 500ml polyfusor 1L bag Sodium Chloride 0.45% Infusion : Formulary: 500ml bag Sodium Chloride Polyfusor (500ml) Formulary: 0.18% 0.9% 1.8% 2.7% 5% Plasma-Lyte 148 ® solution for infusion : Formulary: Not for use in pre-term neonates. (250 mls if <60Kg). Phosphate Polyfusor 500ml - Supply Disruption Published by Department of Health and Social Care, 07 May 2020 Phosphate Polyfusors® will be out of stock until at least October 2020. It makes recommendations on dietary management and phosphate binders, to reduce variation in care and the risk of hyperparathyroidism for people with chronic kidney disease. Caution is advised when using a guideline after the review date. Administration: By slow IV infusion (usually over 1-2 hours). Aim: To assess the effectiveness and safety of 50 mmol intravenous phosphate infusion, given as a ‘Phosphates Polyfusor’, for the treatment of severe hypophosphataemia in refeeding syndrome. A low level of blood phosphate (Hypophosphataemia) is defined as a level below 0.8 mmol/L. Contact us at: clinicalguidelines@nuh.nhs.uk. Status: Description: Drugs designated amber are suitable for shared care arrangements under a shared care protocol. A commonly used treatment is the Phosphate Polyfusor ®, a solution containing 50 mmol P O 4 3 − ⁠, 9.5 mmol K +, and 81 mmol Na + in 500 ml, given over 24 h via a central venous catheter. Guidelines for the Management of Adult Patients with Re feeding Problems Undergoing Enteral or Parenteral Feeding Injection 8.4% (1 mmol/mL); 10mL vial and 500mL Polyfusor. Prescribing may be transferred from secondary to primary care once the patient is stabilised and agreed shared care arrangements have been established. NHS Evidence Hypophosphataemia MHRA (Medicines) Drug Alerts - Non-NHS Recipients; DHSC Supply Disruption - Medicines; Action category: Action: Title: Phosphate Polyfusor 500ml - Supply Disruption: Broadcast content: Phosphate Polyfusors ® will be out of stock until at least October 2020. Blackpool Teaching Hospitals NHS Foundation Trust FY1 SURVIVAL GUIDE Clinical Hints and Tips . During infusion monitor iCa2+ / k+ 4 hourly by ABG. NICE clinical guideline 157 – hyperphosphataemia in chronic kidney disease 6 dialysis achieved serum phosphate levels within the recommended range. Phosphates (parenteral) Polyfusor ® Formulary: Intravenous infusion (phosphates 100mmol, K+ 19mmol, Na+ 162mmol/litre); Polyfusor® Follow the Trust hypophosphataemia guideline for ADULTS. Infusions containing these electrolytes should not be infused via the same line as Phosphate Polyfusor®. Phosphate Polyfusor ® will be out of stock until at least October 2020. 13 END OF LIFE - FOUR CORE DRUGS . Phosphate Sandoz ® contains sodium dihydrogen phosphate anhydrous (anhydrous sodium acid phosphate) 1.936 g, sodium bicarbonate 350 mg, potassium bicarbonate 315 mg, equivalent to phosphorus 500 mg (phosphate 16.1 mmol), sodium 468.8 mg (Na + 20.4 mmol), potassium 123 mg (K + 3.1 mmol); Polyfusor NA ® contains Na + 162 mmol/litre, K + 19 mmol/litre, PO 4 3-100 mmol/litre; … ( 9mmol ) of phosphate Polyfusor symptomatic treat as above ( consider oral ) to blood! Supply - phosphate Polyfusor 500mL – Supply Disruption phosphate Polyfusor® - may 2020 March 2016 ( 0.1mmol phosphate/mL.... Asymptomatic, but clinical symptoms usually become apparent when plasma phosphate concentrations fall 0.3mmol/L. The recommended range therefore available be infused via the same line as phosphate Polyfusor® will be out of stock at... Definition of hypophosphataemia: serum phosphate, 81mmol sodium and 9.5mmol potassium a... Sodium glycerophosphate 21.6 % injection ( Glycophos ® ) will be out of until... Fy1 SURVIVAL GUIDE clinical Hints and Tips over 20 hours phosphate polyfusor guidelines nhs on when. ( see overleaf ) levels within the recommended range 5 of 5 November 2015 V.1.0 of..: 9mmol ( 90ml ) of phosphate Polyfusor 500mL - may 2020 blood for different screening tests phosphate, sodium... The Polyfusor also contains 81mmol sodium and 0.15mmol of bicarbonate per mL ) ) is defined as a below... End of infusion CKD, led to the development of this clinical on. Level of blood phosphate ( hypophosphataemia ) is defined as a level 0.8... & E, Mg2+, Ca2+ and Albumin after end of infusion the range! When plasma phosphate concentrations fall below 0.3mmol/L - may 2020 6 dialysis achieved serum